Trial Profile
Prospective study of efficacy and safety of preoperative transcatheter arterial chemolipiodolization with miriplatin for hepatocellular carcinoma. (Phase I study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Aug 2015
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 01 Mar 2013 New trial record